Daniel R Deaver Selected Research

Daniel R Deaver Research Topics

4	Major Depressive Disorder (Major Depressive Disorders) 12/2019 - 11/2018
2	Alcoholism (Alcohol Abuse) 02/2011 - 06/2008
1	Weight Gain 10/2019
1	Insulin Resistance 10/2019
1	Schizophrenia (Dementia Praecox) 10/2019
1	Cognitive Dysfunction 01/2018
1	Inflammation (Inflammations) 01/2018
1	Morphine Dependence 01/2018
1	Foreign Bodies (Foreign Body) 08/2014
1	Chronic Disease (Chronic Diseases) 08/2014
1	Amphetamine-Related Disorders (Addiction, Amphetamine) 02/2011
1	Acute Pain 06/2008

5	3-carboxamido-4-hydroxynaltrexoneIBA 12/2019 - 01/2018
3	Opioid Analgesics (Opioids)IBA 12/2019 - 06/2008
3	Buprenorphine (Subutex)FDA LinkGeneric 12/2019 - 11/2018
3	Narcotic Antagonists (Opioid Antagonists)IBA 10/2019 - 06/2008
2	Opioid Receptors (Opioid Receptor)IBA 01/2019 - 06/2008
2	CytokinesIBA 01/2018 - 08/2014
2	Naltrexone (ReVia)FDA LinkGeneric 02/2011 - 06/2008
1	mu Opioid Receptors (mu Opioid Receptor)IBA 12/2019
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 12/2019
1	Olanzapine (Zyprexa)FDA Link 10/2019
1	Antipsychotic Agents (Antipsychotics)IBA 10/2019
1	Glucose (Dextrose)FDA LinkGeneric 10/2019
1	ALKS 5461IBA 11/2018
1	CorticosteroneIBA 01/2018
1	MorphinansIBA 01/2018
1	Interferon-alpha (Interferon Alfa)IBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 08/2014
1	Illicit Drugs (Recreational Drugs)IBA 02/2011
1	AmphetaminesIBA 02/2011
1	Delayed-Action PreparationsIBA 06/2008